Hypocholesterolemia in patients with polycythemia vera

Area of Science:

• Hematology
• Cardiovascular Medicine
• Biochemistry

Background:

• Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by increased red blood cell mass.
• PV is paradoxically associated with vascular events despite low serum cholesterol levels.
• Serum cholesterol is no longer a diagnostic criterion for PV since the 2008 WHO classification revision.

Purpose of the Study:

• To investigate the relationship between serum lipid profiles, including total cholesterol, and erythrocytosis.
• To compare lipid profiles between Polycythemia vera (PV) patients and non-PV erythrocytosis patients.
• To explore the mechanism behind hypocholesterolemia in PV.

Main Methods:

• Retrospective review of medical records for 34 erythrocytosis patients (August 2005 - December 2011).
• Analysis of patient demographics, hemoglobin levels, and lipid profiles (total cholesterol, LDL-Ch, apolipoproteins A1 and B).
• In vitro examination of cholesterol efflux into plasma from whole blood samples.

Main Results:

• Patients with PV exhibited significantly lower serum levels of total cholesterol, LDL-Ch, and apolipoproteins A1 and B compared to non-PV erythrocytosis patients.
• In vitro studies demonstrated greater cholesterol release into plasma in PV patients.
• These findings suggest a distinct lipid profile in PV patients.

Conclusions:

• Serum total cholesterol, LDL-Ch, and apolipoproteins A1 and B are lower in Polycythemia vera patients.
• Hypocholesterolemia in PV may result from cholesterol sequestration into the expanded red blood cell mass.
• Further research is warranted to understand the clinical implications of these lipid alterations in PV.